---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-088326"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:01:49.557240+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# iBio preliminary FY2023 net loss $29-29.5M; cash drops to $7.6M; warrants repriced to $0.50

## Summary
- Preliminary FY2023 net loss from continuing ops expected $29.0M-$29.5M vs $29.6M prior year.
- Cash at June 30, 2023: $7.6M (incl $3.3M restricted) down from $28.7M (incl $6M) year ago.
- Common shares outstanding increased to ~22.4M from 8.7M year ago.
- Term note principal balance reduced to ~$13.1M from $22.4M.
- Amended exercise price of Series A and B warrants (covering ~5.5M shares) to $0.50 from $1.04.

## SEC filing metadata
- accession: 0001104659-23-088326
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 1.01, 2.02, 3.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/0001104659-23-088326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/tm2322961d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-088326
- JSON: https://secwatch.observer/filing/0001104659-23-088326.json
- Plain text: https://secwatch.observer/filing/0001104659-23-088326.txt

## Key facts
- Earnings Releases
  iBio, Inc. reported twelve months ending June 30, 2023 results: net income net loss from continuing operations ... to be between $29.0 million and $29.5 million.
  - Period: twelve months ending June 30, 2023
  - Net income: net loss from continuing operations ... to be between $29.0 million and $29.5 million
  - Result: preliminary results
  source text: On a preliminary unaudited basis, the Company expects net loss from continuing operations for the twelve months ending June 30, 2023, to be between $29.0 million and $29.5 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000110465923088326/0001104659-23-088326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.